Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 116821
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116821
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116821
Table 1 Clinical/general information of the subjects
| Group | n | Gender (male/female) | Age (year; median) |
| Health control | 52 | 1.36:1 (30/22) | 39.0 |
| Virus hepatitis | 55 | 1:0.90 (26/29) | 49.0 |
| Non-virus hepatitis | 85 | 1.83:1 (55/30) | 43.0 |
| Liver cirrhosis | 102 | 2.52:1 (73/29) | 43.5 |
| HCC | 138 | 4.52:1 (113/25) | 61.0 |
| HCC patients after radical resection | 93 | 2.88:1 (69/24) | 62.0 |
| HCC recurrence | 26 | 3.33:1 (20/6) | 64.0 |
| χ2 | 29.265 | ||
| P value | < 0.001 |
- Citation: Zhang HY, Zhang RL, Jia YY, Liu Y, Zhu L, Liu F, Rao HY. Diagnostic value of serum chitinase-3-like protein 1 for liver fibrosis/cirrhosis and hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(4): 116821
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/116821.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.116821